FDA
-
Malvern Gene Company to Raise $115M from Convertible Notes While Dealing with Stock Decline
Malvern-based Ocugen saw its stock fall almost 20 percent after an announcement to use convertible notes to pay down existing…
-
Three Philadelphia Scientists Win 2026 Breakthrough Prize for FDA-Approved Gene Therapy Development
Three Philadelphia scientists were recently named the winners of the 2026 Breakthrough Prize for their work in developing the first…
-
With FDA Decision Looming, Plymouth Meeting’s Inovio Cuts Workforce to Preserve Cash
Over the past year, Plymouth Meeting-based Inovio Pharmaceuticals has reduced its workforce by 16 percent to preserve cash as it…
-
Plymouth Meeting Pharmaceutical Company Eyes $1B Milestone
Harmony Biosciences says its flagship narcolepsy drug is on track to hit a major milestone, writes John George for The…
-
First-of-Its-Kind Dry Eye Treatment Spa Comes to Bryn Mawr
A new kind of eye care has arrived on the Main Line, blending medical treatment with spa-style rejuvenation, writes Timothy…
-
As Food Dye Reckoning Nears, Horsham’s Bimbo Bakeries is Ahead of the Curve
As new food regulations begin reshaping the U.S. grocery aisle, Horsham-based Bimbo Bakeries USA is emerging as an industry leader…
-
Bensalem Man Regains Mobility After Injury Thanks to Experimental Drug
Larry Williams, a Bensalem resident left paralyzed after a cycling accident three years ago, has regained the ability to walk…
-
Flagship Drug Sales Boost Plymouth Meeting-Based Harmony Biosciences Stock
Plymouth Meeting-based Harmony Biosciences saw its stock rise by almost 13 percent Thursday after reporting positive sales growth for Wakix,…
-
Merck Finalizes $10 Billion Acquisition, Expands COPD Treatment Portfolio
Pharmaceutical giant Merck, which maintains major operations in Montgomery County, has completed its $10 billion acquisition of Verona Pharma, writes…
-
King of Prussia’s CSL Behring Pioneers Gene Therapy Changing Hemophilia Care
King of Prussia–based CSL Behring is at the center of a medical breakthrough that’s reshaping life for people with hemophilia,…
-
King of Prussia’s SEED Therapeutics Pioneers “Molecular Glue” Cancer Treatments
King of Prussia’s SEED Therapeutics is tackling one of medicine’s toughest challenges, writes Holly Quinn for Technical.ly. The biotech startup…
-
Conshohocken’s ActiveProtective Launches Tango Belt, Eyes Nationwide Expansion
Conshohocken-based ActiveProtective has launched the Tango Belt, a fall prevention device that has been approved by the Food and Drug…
-
West Conshohocken’s SERB Pharmaceuticals Enters Deal to Buy Y-mAbs for $412M
SERB Pharmaceuticals, a Belgian drug developer with U.S. headquarters in West Conshohocken, has reached a $412 million deal to acquire…
-
West Conshohocken’s Madrigal Pharmaceuticals Gets FDA Green Light
West Conshohocken’s Madrigal Pharmaceuticals earned a major win with the FDA approval of its first commercial product, reports John George…
-
WSJ: Merck Makes $10 Billion Move as Keytruda Patent Expiration Nears
Merck is making big pharma waves again with a $10 billion deal to acquire Verona Pharma, reports Colin Kellaher for…
-
Glaxosmithkline Gets Approval for First-of-its-Kind Lupus Treatment
Glaxosmithkline, with multiple operations in Montco, just scored a major regulatory win that could reshape how lupus nephritis is treated…
-
Upper Providence’s GSK Bets Big on ‘Game-Changing’ Liver Disease Drug
GSK has announced a $1.2 billion deal to acquire efimosfermin alfa from Boston Pharmaceuticals, writes John George for the Philadelphia…
-
WCU Alumnus Jake Henry Wins First Place at Salisbury University’s Prestigious Shore Hatchery Competition
West Chester University (WCU) alumnus Jake Henry won first place and a $35,000 prize at the Philip E. and Carole…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
